Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-26-002576

Options or other derivatives

  • Chief Scientific Officer acquired 166,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-30 Grant or award : show line 1 in the form Stock Option (right to buy) +160,000 160,000 D
2026-01-30 Grant or award : show line 2 in the form Stock Option (right to buy) +6,500 6,500 I
Loading xslF345X05/rdgdoc.xml…